Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy
Open Access
- 1 May 1997
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 8 (5), 477-483
- https://doi.org/10.1023/a:1008279222625
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Phase II Trial of High-Dose Carboplatin and Etoposide With Autologous Bone Marrow Transplantation in First-Line Therapy for Patients With Poor-Risk Germ Cell TumorsJNCI Journal of the National Cancer Institute, 1993
- Para‐aortic Lymphadenectomy after Chemotherapy for Metastatic Non‐seminomatous Germ Cell Tumours: Prognostic Value and Therapeutic BenefitBritish Journal of Urology, 1993
- POMBACE chemotherapy in non-seminomatous germ cell tumours: Outcome and importance of dose intensityEuropean Journal Of Cancer, 1992
- Two different classes of therapy-related and de-novo acute myeloid leukemia?Cancer Genetics and Cytogenetics, 1991
- Hematologic Neoplasia Associated with Primary Mediastinal Germ-Cell TumorsNew England Journal of Medicine, 1990
- Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumoursEuropean Journal of Cancer and Clinical Oncology, 1989
- Severe vascular toxicity associated with vinblastine, bleomycin, and cisplatin chemotherapyCancer Chemotherapy and Pharmacology, 1987
- High-dose cisplatin and VP-16 with bleomycin, in the management of advanced metastatic germ cell tumorsEuropean Journal of Cancer and Clinical Oncology, 1986
- FURTHER ADVANCES IN THE MANAGEMENT OF MALIGNANT TERATOMAS OF THE TESTIS AND OTHER SITESThe Lancet, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958